---
layout: default
nav_exclude: true
title: Ado-trastuzumab emtansine
---

# Ado-trastuzumab emtansine

**Generic Name:** Ado-trastuzumab emtansine

**Usage:** Ado-trastuzumab emtansine is used to treat HER2-positive breast cancer.  Specifically, it's used in patients who have already received at least two other treatments for metastatic breast cancer.  It is often used after trastuzumab and a taxane have failed.  Its use may also extend to other HER2-positive cancers, depending on clinical trial results and regulatory approvals.  Always consult your doctor for the most up-to-date and specific usage information.


**Side Effects:**  Ado-trastuzumab emtansine can cause a range of side effects, some common and some rare but serious.  These can include:

* **Common side effects:**  Fatigue, nausea, vomiting, diarrhea, loss of appetite, hair loss (alopecia), low blood counts (neutropenia, thrombocytopenia, anemia), peripheral neuropathy (numbness or tingling in the hands and feet), constipation.

* **Serious side effects:**  Low white blood cell count (neutropenia) increasing the risk of infection, liver problems (hepatotoxicity), lung problems (interstitial lung disease), heart problems (cardiomyopathy), severe allergic reactions.

This is not an exhaustive list, and the severity and frequency of side effects can vary significantly between individuals.  It's crucial to report any unusual or worsening symptoms to your doctor immediately.


**How it Works:** Ado-trastuzumab emtansine is an antibody-drug conjugate (ADC).  It works by targeting HER2 receptors, which are often overexpressed in certain breast cancer cells.  The "trastuzumab" part of the drug is a monoclonal antibody that binds specifically to the HER2 receptors.  The "emtansine" part is a chemotherapy drug (a microtubule inhibitor) that's attached to the antibody.  When the drug binds to the HER2 receptors, it delivers the chemotherapy directly to the cancer cells, minimizing damage to healthy cells. This targeted delivery is what makes it more effective than traditional chemotherapy.


**FAQs:**

* **Q: Is ado-trastuzumab emtansine chemotherapy?** A:  While it contains a chemotherapy drug (emtansine), it's considered a targeted therapy because of its mechanism of action, delivering the chemotherapy specifically to HER2-positive cancer cells.

* **Q: How is ado-trastuzumab emtansine administered?** A: It is administered intravenously (IV) by a healthcare professional.

* **Q: What are the long-term effects of ado-trastuzumab emtansine?** A: Long-term effects can vary, and ongoing monitoring is important. Some potential long-term issues include heart damage (cardiomyopathy) and peripheral neuropathy.  Regular checkups with your doctor are essential.

* **Q: Are there any interactions with other medications?** A: Yes, there can be interactions. It's crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking.

* **Q: Who should not use ado-trastuzumab emtansine?** A:  Patients with severe hypersensitivity to the drug or its components should not use it.  Those with significant pre-existing heart conditions may also be unsuitable candidates. Your doctor will assess your suitability.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult with a healthcare professional before starting any treatment for medical conditions. They can provide personalized advice based on your individual health status and medical history.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.